Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
7
Number of overlapping holdings
14.6%
% of CANC's 48 holdings also in ARKG
25.0%
% of ARKG's 30 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus ARKG)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in ARKG |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 2.6% | 1.7% | 1.7% |
|
NURIX THERAPEUTICS, INC. | 1.3% | 1.8% | 1.3% |
|
REGENERON PHARMACEUTICALS | 1.3% | 0.8% | 0.8% |
|
INCYTE CORP | 0.7% | 1.0% | 0.7% |
|
SCHRODINGER, INC. | 0.6% | 5.2% | 0.6% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to ARKG
|
REVOLUTION MEDICINES, INC. | 5.7% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.9% |
|
ELI LILLY & CO | 4.9% |
|
BRIDGEBIO PHARMA, INC. | 4.4% |
 |
ASTRAZENECA PLC | 4.1% |
|
NOVARTIS AG | 4.1% |
|
SUMMIT THERAPEUTICS INC | 4.1% |
|
NUVALENT, INC. CLASS A | 3.9% |
|
EXELIXIS INC | 3.8% |
|
BRISTOL-MYERS SQUIBB CO | 3.7% |
CANC Underweight Relative to ARKG
|
TWIST BIOSCIENCE CORP. | -8.6% |
|
CRISPR THERAPEUTICS AG | -7.8% |
|
RECURSION PHARMACEUTICALS, INC CLASS | -7.0% |
|
NATERA INC | -6.1% |
|
ADAPTIVE BIOTECHNOLOGIES CORP. | -6.1% |
|
GUARDANT HEALTH, INC. | -5.8% |
|
SCHRODINGER, INC. | -4.6% |
|
BEAM THERAPEUTICS, INC. | -4.2% |
|
VERACYTE INC | -3.6% |
|
CAREDX, INC. | -3.4% |